SavedAdd your journal

Journals / OTOSCOPE / 2002 / Cilt: 3 - Sayı: 1

Early determinated sensory-neural hearing loss by electrophysiological testing in patients with diabetes mellitus

Diabetes mellituslu hastalarda işitme kayıplarının elektrofizyolojik testlerle erken saptanması

İsmail BOYRAZ
Bülent AĞIRDIR
Kenan GÜNEY
Oktay DİNÇ
Hasan ÖZÇAĞLAR
Sevilay KILINÇARSLAN
Journal
OTOSCOPE
Pages
11–18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The effectiveness of BERA and DPOAE in early stage (subclinic) hearing loss is emphasized.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:22 patients with Diabetes Mellitus who have no complaints of hearing loss underwent Brainstem Auditory Evoked Response (BERA) and Distortion Product Otoacoustic Emission (COPOAE) tests.
📊
Key Findings & Data:Findings of these patients were compared with the findings of the control-group that consisted of 10 healthy subjects.
💡
Conclusion & Impact:The effectiveness of BERA and DPOAE in early stage (subclinic) hearing loss is emphasized.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Diabetes mellitus · Uyarılma potansiyelleri · işitsel

Abstract

22 patients with Diabetes Mellitus who have no complaints of hearing loss underwent Brainstem Auditory Evoked Response (BERA) and Distortion Product Otoacoustic Emission (COPOAE) tests. Findings of these patients were compared with the findings of the control-group that consisted of 10 healthy subjects. BERA results of diabetic patients showed elongation of the peripheral and central nerve transmission time compared with the control group. With DPOAE, cochlear pathology is also demonstrated. The elongation of the peripheral nerve transmission time of diabetic patients is thought to be in relation with microangiopathy and central nerve transmission time with the neuropathy. The correlations between BERA and DPOAE values and duration, therapeutic control and modality of the treatment of Diabetes Mellitus are also investigated. The effectiveness of BERA and DPOAE in early stage (subclinic) hearing loss is emphasized.

Özet

İşitme kaybı yakınması olmayan, saf ses ve impedans odyometrisi normal bulunan 22 diabetes mellituslu hasta, beyin sapı işitsel uyarılmış potansiyelleri (BİUP) ve distortion product otoakustik emisyon (DPOAE) testleri ile değerlendirildi. Bulgular, 10 sağlıklı kişiden oluşan kontrol grubuna ait sonuçlarla karşılaştırıldı. Diabetik hastalara ait BİUP ölçümlerinde elde ettiğimiz değerler, periferik iletim zamanı ve santral iletim zamanında uzama şeklinde görüldü. DPOAE ölçümleri ile de kohlear patoloji daha açık bir şekilde tespit edildi. Periferik iletim zamanındaki uzama diabetes mellitusdaki mikroanjiopati ile, santral iletim zamanındaki uzama da nöropati ile ilişkilendirildi. BİUP ve DPOAE değerleri ile diabet süresi, diabetin kontrolü ve tedavi şekli arasındaki ilişki araştırıldı. BİUP ve DPOAE ölçümlerinin erken dönem (subklinik) işitme kayıplarındaki değeri vurgulandı.

🔖

Cite This Article

BOYRAZ, İ., AĞIRDIR, B., GÜNEY, K., DİNÇ, O., ÖZÇAĞLAR, H., KILINÇARSLAN, S. (2002). Early determinated sensory-neural hearing loss by electrophysiological testing in patients with diabetes mellitus. OTOSCOPE, Cilt: 3 - Sayı: 1, 11–18. https://ajindex.com/articles/286748

References (19)

  1. Kurien M, Thomas K, Bhanu TS. Hearing thresholds in patients with diabetes mellitus. J Laryngol Otol 1989; 103:164-8
  2. Virtaniemi J, Laakso M, Nuutinen J. Hearing thresholds in insulin-dependent diabetic patients. J Laryngol Otol 1994; 108:837-41
  3. Harner SG. Hearing in adult on-set diabetes mellitus. Otolaryngol Head Neck Surg. 1981; 89:322-7
  4. Gates G, Cobb JL, D'Agustino RB at al. The relation of hearing in elderly to the presence of cardivascular disease and cardivascular risk factors. Arch Otolaryngol Head Neck Surg. 1993;119:156-61
  5. Fowler PD, Jones NS. Diabetes and hearing loss. Clin Otolaryngol 1999;24:3-8
  6. Wackym PA, Lmthicum FH. Diabetes Mellitus and hearing loss:clinical and histopatological relationship. Am J Otolaryngol 1986; 7:176-82
  7. Chapman T Me, Andrew B, Timothy LS. Non-insulin- dependent diabetic microangiopathy in the inner ear. J Laryngol Otol 1999;113:13-8
  8. Myers F S, Ross M, Jokelainen R Morphological Evidence of Vestibular Pathology in Long-term Experimental Diabetes Mellitus. Acta Otolaryngol 1985; 100:351-64
  9. Jorgenson M, Buch N. Studies on inner ear function and cranial nerves in diabetes. Acta Otolaryngol 1961; 53:350-64
  10. Costa OA. Inner ear pathology in experimental diabetes mellitus. Laryngoscope 1967; 77:68-75
  11. Makıshıma K, Tanaka K. Pathological changes of the inner ear and central auditory pathway in diabetics. Ann Otol Rhino Laryngol 1971; 80:218-28
  12. Kovar M. The inner ear in diabetes mellitus. ORL1973; 35:42-51
  13. Axelsson A, Sigroth K, Vertes D. Hearing in diabetes.Acta otolaryngologica. 1978; 356:1-23
  14. Önol H.Ç. Normoakustik diabetes mellituslu hastalarda beyin sapı işitsel uyarılmış potansiyelleri. Uzmanlık tezi. Akdeniz Üniv.Tıp Fak.1992
  15. Lemaire MC, Beutter P. Brainstem auditory evoked responses in patients with tinnutus. Audiology 1995; 34:287-300
  16. Özgirgin N, Vural O. Gürültüye bağlı işitme kayıplı kobaylarda beyinsapı uyarılmış cevap odyometrisi. ERA. Otolaringoloji ve Stomatoloji dergisi. Temmuz 1987; 67- 72
  17. Fred FT, Thieray M, Mark A, et al. Comparison of the auditory -evoked brainstem response wave to DPOAE resulting from changes to inner ear blood flow. Laryngoscope 1999; 109:186-91
  18. Marullo T. Contribution a letude des hypoacousies perceptives du diabete sucre. Rev Laryngol 1975; 95: 253-71
  19. Martini A, Comacchio F, Molinari G, et al. Auditory brainstem evoked responses as a function of stimulus repetetion in diabetes mellitus. Adv Audiol 1985;3: 1